Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K250504
    Device Name
    Leonardo Duster
    Manufacturer
    Date Cleared
    2025-07-14

    (144 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Leonardo Duster

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Leonardo® Duster is intended for incision, excision, resection, ablation, coagulation, hemostasis, and vaporization of soft tissue, with or without an endoscope, in the following indications: urology, lithotripsy, gastroenterological surgery and gynecological surgery.

    Urology

    • Ablation of Benign Prostatic Hyperplasia (Hypertrophy) [BPH]
    • Laser Resection of the Prostrate (LRP)
    • Laser Enucleation of the Prostate (LEP)
    • Laser Ablation of the Prostate (LAP)
    • Transurethral Incision of the Prostate (TUIP)
    • Condylomas
    • Urethral/ureteral structures
    • Lesions of external genitalia
    • Bladder neck incisions (BNI)
    • Ablation and resection of bladder tumors, urethral tumors, and ureteral tumors
    • Endoscopic fragmentation of urethral, ureteral, bladder, and renal calculi
    • Treatment of distal impacted fragments remaining in the ureters following lithotripsy

    Lithotripsy and Percutaneous Urinary Lithotripsy Indications

    • Endoscopic fragmentation of urethral, ureteral, bladder and renal calculi including cystine, calcium oxalate, monohydrate and calcium oxalate dehydrate stones
    • Endoscopic fragmentation of renal calculi
    • Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed

    Gastroenterology
    Open and endoscopic gastroenterology surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:

    • Appendectomy
    • Polyps
    • Biopsy
    • Gall Bladder calculi
    • Biliary/Bile duct calculi
    • Ulcers
    • Gastric ulcers
    • Duodenal ulcers
    • Non Bleeding Ulcers
    • Pancreatitis
    • Haemorrhoids
    • Cholecystectomy
    • Benign and Malignant Neoplasm Gynecology
    • Angiodysplasia
    • Colorectal cancer
    • Telangiectasias
    • Telangiectasias of the Osler-Weber-Renu disease
    • Vascular Malformation
    • Gastritis
    • Esophagitis
    • Esophageal ulcers
    • Varices
    • Colitis
    • Mallory-Weiss tear
    • Gastric Erosions

    Gynecology
    Open, endoscopic (including hysteroscopic) and laparoscopic gynecological surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue.

    Device Description

    All variants of the laser family LEONARDO® Duster are laser systems with functions and ergonomics specially developed for medical applications. A touchscreen is used to set treatment parameters, such as Power in Continuous mode, Pulse energy (J) and Frequency (Hz) with Pulse width options in Pulse mode. User-friendly menu navigation and microprocessor-supported control ensure reliable operation while allowing physicians to concentrate on the essential aspects of treatment. The Thulium doped fiber laser module produce a coherent laser radiation with the wavelength of 1940nm±3nm (aiming beam 525nm +/-10nm). An optical fiber delivers this energy to affected surfaces and organs. All fields of application are listed in the indications for use statement.

    The subject model LEONARDO® Duster laser has a maximum laser output power of 60W. @ 1940nm The LEONARDO® Duster is available only as a single-wavelength device with 1940nm. All LEONARDO® Duster lasers can be operated in two basic modes, CONTINUOUS or PULSE MODE. Two application modes are available which defines the intended use of the device: Lithotripsy and Other. For safety reasons, the LEONARDO® Duster laser is equipped with a system for automatic recognition of the used optical fibers. Application fibers from CeramOptec are RFID encoded for communicating with the laser device. Reusable fiber probes are available in 6 different sizes. They are initially EO sterilized. Subsequent sterilization is via autoclave. Single patient use fiber probes come in 7 different sizes. They are initially EO sterilized.

    AI/ML Overview

    This document is a 510(k) clearance letter for the Leonardo Duster laser system. It asserts substantial equivalence to a predicate device based on non-clinical testing. This type of clearance typically relies on demonstrating that a new device is as safe and effective as a legally marketed predicate device, often without requiring new clinical trials for effectiveness if the indications for use and technological characteristics are sufficiently similar.

    Therefore, the provided text does not describe a study involving acceptance criteria related to device performance in a clinical or AI-centric context, nor does it present acceptance criteria for an AI-powered device. It primarily focuses on the safety and effectiveness of a physical medical device (a laser surgical instrument) compared to a predicate device, which is a common pathway for 510(k) clearance.

    The "acceptance criteria" presented here are inferred from the regulatory requirements for 510(k) clearance, namely, demonstrating substantial equivalence to a predicate device based on:

    1. Identical Indications for Use.
    2. Similar technological characteristics without raising new questions of safety or effectiveness.
    3. Compliance with relevant performance standards and non-clinical testing (e.g., software validation, reprocessing validation, biocompatibility, sterilization, electrical safety, EMC, usability, laser safety).

    Since this is not an AI/ML device or a comparative effectiveness study, many of the requested fields (e.g., sample size for test set, data provenance, ground truth experts, adjudication, MRMC study, standalone performance, training set size) are not applicable.

    Here's the breakdown based on the provided text's focus on a physical laser device clearance:

    Acceptance Criteria and Device Performance (Based on Substantial Equivalence Determination)

    Acceptance Criteria CategorySpecific Criteria (Inferred from 510(k))Reported Device Performance (Leonardo Duster)
    Indications for UseIdentical to predicate deviceIdentical to predicate device (SOLTIVE™ Laser System) across Urology, Lithotripsy, Gastroenterology, and Gynecology.
    Technological CharacteristicsSubstantially similar to predicate device; no new safety/effectiveness issues.Similar in display, mode, laser power (60W), laser type (Thulium), wavelength (1940nm), aiming beam (525nm vs. 500-550nm), laser class (4), operation mode (Pulsed, CW), pulse frequency (1-2500 Hz), cooling (air), main power supply (100-240 Vac; 50/60 Hz). Pulse length/duration (0.04-50ms vs. 0.2-50ms) is "nearly identical." Dimensions are "similar." Weight is "slightly heavier" (41kg vs. 33kg), but not considered a safety/effectiveness issue for this type of device.
    Safety TestingCompliance with relevant electrical safety, EMC, laser safety, and usability standards.Complies with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-2-22, IEC 60825-1, and 21 CFR 1040.
    Software ValidationCompliance with FDA Guidance: Content of Premarket Submissions for Device Software Functions.Firmware validated according to FDA Guidance (2023) with "basic level of documentation." Complies with IEC 62366-1.
    BiocompatibilityCompliance with ISO 10993 series for cytotoxicity, irritation, hypersensitivity, pyrogenicity, systemic toxicity, leachable substances, and chemical characterization.Complies with ISO 10993-5, -10, -11, -17, -18, and ISO/TS 21726.
    SterilizationCompliance with ISO 11135, EN ISO 11737-2, and EN 556-1 for reusable and single-patient use fiber optic probes.Complies with ISO 11135, EN ISO 11737-2, EN 556-1 for both reusable (autoclave) and single-patient use (EO sterilization) probes.
    Reprocessing ValidationValidation according to FDA Guidance: Reprocessing Medical Devices in Health Care Settings.Reprocessing validation performed for reusable fiber optic probes according to FDA Guidance.
    Risk ManagementApplication of risk management to medical devices according to ISO 14971.Complies with ISO 14971:2019-12.
    Labeling/InformationCompliance with EN 1041 and IEC ISO 15223-1.Complies with EN 1041 and IEC ISO 15223-1.

    Study Details Pertaining to the Leonardo Duster 510(k) Clearance

    1. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

      • N/A. This 510(k) clearance is based on non-clinical (bench) testing and comparison to a predicate device, not a performance study on a test set of data (like for an AI/ML device). The "test set" in this context refers to physical devices and components being tested in a lab setting. These tests were conducted by "accredited testing laboratories," but the location is not specified beyond "Bonn, Nordrhein-Westfalen, Germany" for the manufacturer. No patient data is involved in this type of submission.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

      • N/A. No ground truth established by medical experts for a "test set" of patient data was carried out. The "ground truth" for a physical device like this is its adherence to engineering specifications and regulatory performance standards.
    3. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

      • N/A. No adjudication of expert opinions on medical cases was performed as this is not a clinical or AI performance study.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No. An MRMC study was not done. This is a physical laser surgical instrument, and the clearance is for the device itself, not an AI/ML component assisting human readers.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

      • No. This is not an algorithm, but a physical medical device. Software validation was performed for the device's firmware, but this does not represent a "standalone algorithm" performance in the context of AI/ML.
    6. The type of ground truth used (expert concensus, pathology, outcomes data, etc):

      • N/A. As this is a physical device, the "ground truth" for its clearance is based on its adherence to engineering specifications, national and international consensus standards for medical devices (e.g., electrical safety, laser safety, biocompatibility, sterilization, usability), and its functional output parameters (e.g., laser power, wavelength, pulse characteristics). There's no clinical "ground truth" like pathology or outcomes data presented for this 510(k) summary, as "Clinical testing was not required to establish substantial equivalence."
    7. The sample size for the training set:

      • N/A. No training set was used as this device is a physical laser surgical instrument, not an AI/ML algorithm.
    8. How the ground truth for the training set was established:

      • N/A. No training set was used.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1